Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $43,595 | 9 | 76.2% |
| Honoraria | $11,760 | 4 | 20.6% |
| Travel and Lodging | $1,431 | 5 | 2.5% |
| Food and Beverage | $419.08 | 5 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $24,741 | 9 | $0 (2023) |
| Amgen Inc. | $16,744 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $9,935 | 1 | $0 (2020) |
| Novo Nordisk Inc | $5,658 | 6 | $0 (2017) |
| Madrigal Pharmaceuticals | $97.73 | 1 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $17.13 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $12.17 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $97.73 | 1 | Madrigal Pharmaceuticals ($97.73) |
| 2023 | $20,104 | 6 | PFIZER INC. ($10,500) |
| 2022 | $18,060 | 4 | PFIZER INC. ($10,920) |
| 2021 | $840.00 | 1 | PFIZER INC. ($840.00) |
| 2020 | $9,935 | 1 | AstraZeneca Pharmaceuticals LP ($9,935) |
| 2018 | $2,481 | 2 | PFIZER INC. ($2,481) |
| 2017 | $5,687 | 8 | Novo Nordisk Inc ($5,658) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/11/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $97.73 | General |
| Category: LIVER DISEASE | ||||||
| 10/16/2023 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $7,140.00 | General |
| 10/16/2023 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $2,380.00 | General |
| 10/16/2023 | Amgen Inc. | — | Travel and Lodging | Cash or cash equivalent | $83.69 | General |
| 07/24/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| 06/16/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| 03/17/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $7,350.00 | General |
| 08/24/2022 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $7,140.00 | General |
| 05/23/2022 | PFIZER INC. | — | Honoraria | Cash or cash equivalent | $3,080.00 | General |
| 01/28/2022 | PFIZER INC. | — | Honoraria | Cash or cash equivalent | $140.00 | General |
| 01/14/2022 | PFIZER INC. | — | Honoraria | Cash or cash equivalent | $7,700.00 | General |
| 09/24/2021 | PFIZER INC. | — | Honoraria | Cash or cash equivalent | $840.00 | General |
| 11/10/2020 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $9,934.50 | General |
| 03/19/2018 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 03/19/2018 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $481.32 | General |
| 11/12/2017 | Bayer HealthCare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $17.13 | General |
| 10/26/2017 | Novo Nordisk Inc | FIASP (Drug) | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| Category: Diabetes | ||||||
| 10/26/2017 | Novo Nordisk Inc | FIASP (Drug) | Travel and Lodging | In-kind items and services | $354.84 | General |
| Category: Diabetes | ||||||
| 10/26/2017 | Novo Nordisk Inc | FIASP (Drug) | Travel and Lodging | In-kind items and services | $284.98 | General |
| Category: Diabetes | ||||||
| 10/26/2017 | Novo Nordisk Inc | FIASP (Drug) | Travel and Lodging | In-kind items and services | $226.12 | General |
| Category: Diabetes | ||||||
| 10/26/2017 | Novo Nordisk Inc | FIASP (Drug) | Food and Beverage | In-kind items and services | $182.79 | General |
| Category: Diabetes | ||||||
| 06/10/2017 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $109.26 | General |
| Category: Diabetes | ||||||
| 02/14/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $12.17 | General |
About Dr. Evan Abel, MD
Dr. Evan Abel, MD is a Internal Medicine healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619067238.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Evan Abel, MD has received a total of $57,205 in payments from pharmaceutical and medical device companies, with $97.73 received in 2024. These payments were reported across 23 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($43,595).
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Santa Monica, CA
- Active Since 10/13/2006
- Last Updated 12/02/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1619067238
Products in Payments
- FIASP (Drug) $5,549
- Tresiba (Drug) $109.26
- RESMETIROM (Drug) $97.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Santa Monica
Dr. Przemyslaw Twardowski, Md, MD
Internal Medicine — Payments: $1.2M
Richard Finn, Md, MD
Internal Medicine — Payments: $1.1M
Saeed Sadeghi, Md, MD
Internal Medicine — Payments: $809,489
Zev Wainberg, Md, MD
Internal Medicine — Payments: $745,774
Dr. Stephen Kania, M.d, M.D
Internal Medicine — Payments: $707,242
Dr. Jonathan Goldman, M.d, M.D
Internal Medicine — Payments: $264,528